[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100517545":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":11,"locations":17,"responsibleParty":33,"collaborators":7,"id":37,"slug":7,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":43,"sex":44,"minAge":7,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":53,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Sichuan Cancer Hospital and Research Institute","OTHER",null,[9],{"type":6,"name":10,"description":10,"armGroupLabels":7,"otherNames":7},"No intervention",[12],{"name":13,"role":14,"phone":15,"phoneExt":7,"email":16},"Dengfeng Wang, Learned scholar","CONTACT","15982222707","wonderful_96@163.com",[18],{"facility":19,"status":20,"city":21,"state":7,"zip":7,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"Sichuan Cancer Hospital","RECRUITING","Chengdu","China","CN",{"type":25,"coordinates":26},"Point",[27,28],104.06667,30.66667,{"lat":28,"lon":27},[31],{"name":32,"role":14,"phone":15,"phoneExt":7,"email":16},"Wang Dengfeng, Doctor",{"type":34,"investigatorFullName":35,"investigatorTitle":36,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Dengfeng Wang","Deputy chief","100517545",false,"NCT06018935","A Cohort Establishment Study of Total Management of Ovarian Cancer","A Cohort Establishment Study of Total Management of Ovarian Cancer (Including Fallopian Tube Cancer and Primary Peritoneal Cancer)","Inclusion Criteria:\n\n1. Patients diagnosed with ovarian cancer (including fallopian tube cancer, primary peritoneal cancer) and intended to be treated in our hospital;\n2. Can cooperate with later follow-up.\n\nExclusion Criteria:\n\n1. Patients with other malignant tumors or previous history of other malignant tumors;\n2. Have cognitive impairment.",true,"FEMALE",{"count":46,"type":47},500,"ESTIMATED","OBSERVATIONAL","A cohort establishment study of total management of ovarian cancer (including fallopian tube cancer and primary peritoneal cancer).",[51,52],"Tumor of Female Reproductive System","Ovarian Cancer",[54,55,56],"Ovarian cancer","Cohort study","Whole-process management","2024-06-17",{"date":59,"type":60},"2024-06-20","ACTUAL",{"date":57,"type":60},{"date":63,"type":47},"2025-09-01",{"name":5,"class":6},1]